Thermaquil, Inc.

Drug-free nerve block devices

Philadelphia, United States · Founded 2019 · $1.0M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$1.0M
Last Round
$1.0M Grant
Rounds
1

About

Thermaquil develops drug-free, non-addictive nerve block devices that use gentle thermal cycling to block pain signal transmission without drugs or electrical stimulation. Their flagship wearable device targets patients with chronic migraine, occipital pain, and post-surgical thoracic pain. The technology provides patient-controlled, reversible nerve modulation and is being validated in sham-controlled clinical studies.

Summary

Thermaquil, Inc. is a Healthcare company based in Philadelphia, United States, founded in 2019. It has raised $1.0M in total across 1 round. Investors include NSF SBIR.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

$1.0M

Investors

Similar Companies